Hypophosphatemia risk higher with ferric carboxymaltose in IBD-related anemia

Ferric carboxymaltose induced a higher rate of hypophosphatemia compared with ferric derisomaltose among patients with inflammatory bowel disease-associated iron deficiency anemia, according to results published in Gut.“Anemia is the most common extraintestinal manifestation of IBD, and iron deficiency and inflammation are its leading causes. … The European Crohn’s and Colitis Organization recommends high-dose intravenous iron as a first-line treatment for iron deficiency anemia (IDA) in patients with IBD,” Heinz Zoller, MD, associate professor of medicine at the MedicalRead More